C07D 235/32
Benzimidazole-2-carbamic acids, unsubstituted or substituted
Official title: Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
C07D235/32 (Benzimidazole-2-carbamic acids, unsubstituted or substituted) appears on 143 US grants and 64 published applications in this corpus.
Search patents in C07D- Granted patents
- 143
- Published applications
- 64
- Assignees
- 71
- Inventors
- 348
- Latest grant
- 1 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 8 | 0 |
| 1978 | 9 | 0 |
| 1979 | 9 | 0 |
| 1980 | 3 | 0 |
| 1981 | 8 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 3 |
| 2003 | 5 | 3 |
| 2004 | 3 | 8 |
| 2005 | 3 | 3 |
| 2006 | 5 | 5 |
| 2007 | 2 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 4 |
| 2011 | 3 | 1 |
| 2012 | 4 | 0 |
| 2013 | 1 | 4 |
| 2014 | 2 | 3 |
| 2015 | 3 | 3 |
| 2016 | 2 | 1 |
| 2017 | 2 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 5 |
| 2021 | 1 | 2 |
| 2022 | 2 | 2 |
| 2023 | 3 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mebendazole prodrugs with enhanced solubility and oral bioavailability1 Aug 2023US 11,712,435 B2Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Compounds for treating proliferative diseases11 Jul 2023US 11,697,640 B2Beth Israel Deaconess Medical Center, Inc.
- Compositions and methods for the treatment and imaging of cancer21 Mar 2023US 11,607,464 B2Board of Regents of the University of Nebraska
- Benzimidazole derivatives as adenosine receptor antagonists27 Sep 2022US 11,453,647 B2Merck Patent GmbH
- Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases15 Feb 2022US 11,247,972 B2University of Washington through its Center for Commercialization
- Treatment methods16 Apr 2026US 2026/0102407 A1
- Thiobenzimidazole derivative or pharmaceutically acceptable salt thereof, and use thereof3 Jul 2025US 2025/0214945 A1Korea University Research and Business Foundation
- Thiobenzimidazole derivative preparation method and novel intermediate therefor3 Jul 2025US 2025/0214987 A1Korea University Research and Business Foundation
- Therapeutic compounds and uses thereof25 Apr 2024US 2024/0132479 A1Board of Trustees of Michigan State University
- Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as active ingredient11 Apr 2024US 2024/0116897 A1Korea Research Institute of Chemical Technology
Most cited
By later US patents
- Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them57US 5,852,046 AHoechst Aktiengesellschaft · 1998
- Biaryl compounds as serine protease inhibitors57US 6,699,994 B1BioCryst Pharmaceuticals, Inc. · 2004
- Salts of alkyl 2-benzimidazole-carbamate33US 4,046,906 AHoechst Aktiengesellschaft · 1977
- Biphenyl and biphenyl-analogous compounds as integrin antagonists31US 6,420,396 B1Beiersdorf AG · 2002
- Benzamide derivatives having a vasopressin antagonistic activity29US 6,207,693 B1Fujisawa Pharmaceutical Co., Ltd. · 2001